Retrospective multivariate analysis of hepatic veno-occlusive disease after blood or marrow transplantation: Possible beneficial use of low molecular weight heparin

Bone Marrow Transplantation

Volumn 27, Issue 6, 2001, Pages 627-633

  Simon, M ^a   Hahn, T ^a   Ford, L A ^a   Anderson, B ^a   Swinnich, D ^a   Baer, M R ^a   Bambach, B ^a   Bernstein, S H ^a   Bernstein, Z P ^a   Czuczman, M S ^b   Slack, J L ^a   Wetzler, M ^a   Herzig, G ^a   Schriber, J ^a   McCarthy Jr , P L ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b NONE

Author keywords

Blood and marrow transplantation; Heparin; Prophylaxis; Veno occlusive disease

Indexed keywords

ASPARTATE AMINOTRANSFERASE; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; ENOXAPARIN; ETOPOSIDE; HEPARIN; HEPARIN DERIVATIVE; LOW MOLECULAR WEIGHT HEPARIN; MELPHALAN; METHOTREXATE; METHYLPREDNISOLONE; OKT 3; PLACEBO; PROSTAGLANDIN E1; TACROLIMUS; THIOTEPA;

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; AUTOTRANSPLANTATION; BLEEDING; BONE MARROW TRANSPLANTATION; CAUSE OF DEATH; CLINICAL TRIAL; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INCIDENCE; LIVER VENOOCCLUSIVE DISEASE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROPHYLAXIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RELATIVE; RETROSPECTIVE STUDY; RISK FACTOR; SCORING SYSTEM;

ADULT; AGED; BLOOD TRANSFUSION; BONE MARROW TRANSPLANTATION; COHORT STUDIES; DINOPROSTONE; FEMALE; HEPARIN; HEPARIN, LOW-MOLECULAR-WEIGHT; HEPATIC VENO-OCCLUSIVE DISEASE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 17744388789     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702854     Document Type: Article

References (32)

1. Venoocclusive disease of the liver after marrow transplantation: Diagnosis, incidence, and predisposing factors
2. Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: A cohort study of 355 patients
3. Veno-occlusive disease of the liver following bone marrow transplantation
4. The clinical course of 53 patients with veno-occlusive disease of the liver after marrow transplantation
5. An analysis of hepatic venocclusive disease and centrilobular hepatic degeneration following bone marrow transplantation
6. Veno-occlusive disease of the liver after marrow transplantation: Histological correlates of clinical signs and symptoms
7. Prevention of hepatic venoocclusive disease after bone marrow transplantation by continuous infusion of low-dose heparin: A prospective, randomized trial
8. Phase II trial of heparin prophylaxis for veno-occlusive disease of the liver in children undergoing bone marrow transplantation
9. Prophylactic heparin does not prevent liver veno-occlusive disease following autologous bone marrow transplantation
10. Incidence and outcome of hepatic veno-occlusive disease after blood or marrow transplantation: A prospective cohort study of the European Group for Blood and Marrow Transplantation
11. Prevention of veno-occlusive disease of the liver after bone marrow transplantation: Heparin or no heparin?
12. A pilot study of continuous infusion heparin for the prevention of hepatic veno-occlusive disease after bone marrow transplantation
13. Use of prostaglandin E1 for prevention of liver veno-occlusive disease in leukaemic patients treated by allogeneic bone marrow transplantation
14. A phase I/II study of prostaglandin E1 for the prevention of hepatic venocclusive disease after bone marrow transplantation
15. Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis
16. Efficacy and safety of enoxaparin to prevent deep venous thrombosis after hip replacement surgery
17. Low molecular weight heparin for the prevention of veno-occlusive disease of the liver in bone marrow transplantation patients
18. A randomized phase II trial comparing heparin (Hep) +/- Prostaglandin E1 (PG) to prevent hepatotoxicity (HT) following bone marrow transplantation (BMT): Preliminary results
19. Thiotepa-associated cardiomyopathy during blood or marrow transplantation: Association with the female sex and cardiac risk factors
20. High-dose etoposide, cyclophosphamide and total body irradiation with allogeneic bone marrow transplantation for patients with acute myeloid leukemia in untreated first relapse: A study by the North American Marrow Transplant Group
21. Prognostic factors for response and survival after high-dose cyclophosphamide, carmustine, etoposide with autologous bone marrow transplantation for relapsed Hodgkin's disease
22. Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide
23. Aplastic anaemia treated by marrow transplantation
24. Low-risk intensive therapy for multiple myeloma with combined autologous bone marrow transplantation and blood stem cell support
25. Acute graft-versus-host disease: Analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate
26. Cyclosporine and methylprednisolone for prophylaxis of acute graft-versus-host disease
27. Phase II clinical trial of OKT3 for acute graft-versus-host disease (GVHD) prophylaxis in allogeneic bone marrow transplantation (alloBMT)
28. Cyclosporine, methotrexate and prednisone compared with cyclosporine and prednisone for prophylaxis for acute graft-versus-host disease
29. Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation
30. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors
31. Chronic graft-versus-host syndrome in man: A long-term clinico-pathologic study of 20 Seattle patients
32. Tissue plasminogen activator (tPA) as therapy for hepatotoxicity following bone marrow transplantation